{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[32m2025-06-18 18:55:33.259\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.trial.service\u001b[0m:\u001b[36m_parse_patient_data_from_string\u001b[0m:\u001b[36m37\u001b[0m | \u001b[1mPatient data extraction response: {\n",
      "  \"biomarkers\": [\n",
      "    \"ATRX D1940Ifs*15\",\n",
      "    \"IDH1 R132H\",\n",
      "    \"TP53 P250L\",\n",
      "    \"EGFR Amplification\",\n",
      "    \"PDGFRA Amplification\",\n",
      "    \"PTEN Deletion\",\n",
      "    \"MYCN Amplification by FISH (Equivocal)\",\n",
      "    \"Microsatellite Instability (MSI-Stable)\",\n",
      "    \"Tumor Mutation Burden (Low)\",\n",
      "    \"EGFRvIII (Not Detected)\",\n",
      "    \"MGMT Promoter Methylation (Not Detected)\",\n",
      "    \"PD-L1 (Negative/Not Detected)\"\n",
      "  ],\n",
      "  \"histology\": \"Astrocytoma Grade 4\",\n",
      "  \"staging\": \"\",\n",
      "  \"ecog_performance_status\": \"\",\n",
      "  \"first_line_treatment\": \"Surgery, Radiation with Temozolomide (TMZ), Chemotherapy (TMZ)\",\n",
      "  \"second_line_treatment\": \"Stereotactic radiation, Lomustine (discontinued), Carboplatin (discontinued), Avastin (bevacizumab) monotherapy\",\n",
      "  \"age\": \"37\"\n",
      "}\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:33.260\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.trial.service\u001b[0m:\u001b[36m_parse_patient_data_from_string\u001b[0m:\u001b[36m39\u001b[0m | \u001b[1mParsed patient data: {'biomarkers': ['ATRX D1940Ifs*15', 'IDH1 R132H', 'TP53 P250L', 'EGFR Amplification', 'PDGFRA Amplification', 'PTEN Deletion', 'MYCN Amplification by FISH (Equivocal)', 'Microsatellite Instability (MSI-Stable)', 'Tumor Mutation Burden (Low)', 'EGFRvIII (Not Detected)', 'MGMT Promoter Methylation (Not Detected)', 'PD-L1 (Negative/Not Detected)'], 'histology': 'Astrocytoma Grade 4', 'staging': '', 'ecog_performance_status': '', 'first_line_treatment': 'Surgery, Radiation with Temozolomide (TMZ), Chemotherapy (TMZ)', 'second_line_treatment': 'Stereotactic radiation, Lomustine (discontinued), Carboplatin (discontinued), Avastin (bevacizumab) monotherapy', 'age': '37'}\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:33.260\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.trial.service\u001b[0m:\u001b[36msearch_clinical_trials\u001b[0m:\u001b[36m163\u001b[0m | \u001b[1mParsed patient data: biomarkers=['ATRX D1940Ifs*15', 'IDH1 R132H', 'TP53 P250L', 'EGFR Amplification', 'PDGFRA Amplification', 'PTEN Deletion', 'MYCN Amplification by FISH (Equivocal)', 'Microsatellite Instability (MSI-Stable)', 'Tumor Mutation Burden (Low)', 'EGFRvIII (Not Detected)', 'MGMT Promoter Methylation (Not Detected)', 'PD-L1 (Negative/Not Detected)'] histology='Astrocytoma Grade 4' staging='' ecog_performance_status='' first_line_treatment='Surgery, Radiation with Temozolomide (TMZ), Chemotherapy (TMZ)' second_line_treatment='Stereotactic radiation, Lomustine (discontinued), Carboplatin (discontinued), Avastin (bevacizumab) monotherapy' age='37'\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:34.778\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.trial.service\u001b[0m:\u001b[36msearch_clinical_trials\u001b[0m:\u001b[36m167\u001b[0m | \u001b[1mGenerated clinical trial search criteria: (\"astrocytoma grade 4\" OR \"glioblastoma\" OR \"grade IV astrocytoma\") AND (ATRX OR IDH1 OR TP53 OR EGFR OR PDGFRA OR PTEN OR MYCN)\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.516\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.trial.service\u001b[0m:\u001b[36msearch_clinical_trials\u001b[0m:\u001b[36m171\u001b[0m | \u001b[1mClinical trials found: 24\u001b[0m\n",
      "Number of trials found:  24\n"
     ]
    }
   ],
   "source": [
    "import sys\n",
    "sys.path.append('../../')\n",
    "\n",
    "\n",
    "from triagent.agents.therapy.services.trial.service import TrialService\n",
    "\n",
    "\n",
    "DISEASE = \"glioblastoma\"\n",
    "\n",
    "# Load the patient summary\n",
    "def read_patient_summary(file_path: str):\n",
    "    \"\"\"Read patient summary from the specified markdown file.\"\"\"\n",
    "    try:\n",
    "        with open(file_path, 'r') as file:\n",
    "            content = file.read()\n",
    "            return content\n",
    "    except FileNotFoundError:\n",
    "        print(f\"Patient summary file not found: {file_path}\")\n",
    "        return \"Patient summary not available.\"\n",
    "    except Exception as e:\n",
    "        print(f\"Error reading patient summary: {str(e)}\")\n",
    "        return \"Error reading patient summary.\"\n",
    "\n",
    "patient_info = read_patient_summary(\"cases/11 - astrocytoma-case-summary.md\")\n",
    "\n",
    "trial_service = TrialService()\n",
    "trials = await trial_service.search_clinical_trials(patient_info)\n",
    "print(\"Number of trials found: \", len(trials))\n",
    "\n",
    "# patient_data = await trial_service._parse_patient_data_from_string(patient_info)\n",
    "# case_26_query = \"\"\"\n",
    "# (\"Glioblastoma\" OR \"GBM\") AND (\"WHO grade 4\" OR \"grade 4\" OR \"grade IV\") AND (\"IDH-wildtype\" OR \"IDH wildtype\" OR \"IDH wild-type\" OR \"IDHwt\" OR \"IDH WT\")\n",
    "# \"\"\"\n",
    "# trials = await trial_service._search_clinical_trials_with_query(case_26_query)\n",
    "# print(len(trials))\n",
    "# eligible_trials = await trial_service.match_trials_to_patient(trials, patient_data)\n",
    "# print(len(eligible_trials))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[32m2025-06-18 18:55:35.561\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mrerank_trials\u001b[0m:\u001b[36m155\u001b[0m | \u001b[1mRanking trials for patient: # Patient Summary\n",
      "\n",
      "**Patient**: Not specified  \n",
      "**Age**: 37  \n",
      "**Sex**: Female  \n",
      "**Date of Diagnosis**: December 2022  \n",
      "**Primary Cancer Type**: Astrocytoma Grade 4  \n",
      "**Medical Diagnosis**: Grade 4 Astrocytoma with recurrence  \n",
      "**Current Treatment Status**: Disease progression with multiple tumors; currently on Avastin only\n",
      "\n",
      "## Treatment History\n",
      "\n",
      "**Treatments**:  \n",
      "- Surgery, Radiation, Chemotherapy, Targeted Therapy\n",
      "\n",
      "**Specific Interventions**:  \n",
      "- 12/09/2022: Surgery (100% resection)\n",
      "- 01/2023: Completed radiation with Temozolomide (TMZ)\n",
      "- 01/2023-01/2024: Completed 12 months of TMZ\n",
      "- 03/2024: Stereotactic radiation at Duke for recurrent tumors\n",
      "- Recent: Discontinued Lomustine after unspecified duration\n",
      "- Recent: Discontinued Carboplatin after single treatment\n",
      "- Current: Avastin (bevacizumab) monotherapy\n",
      "\n",
      "## Molecular/Genetic Characteristics\n",
      "\n",
      "**Biomarkers**:  \n",
      "- ATRX D1940Ifs*15\n",
      "- IDH1 R132H\n",
      "- TP53 P250L\n",
      "- EGFR Amplification: AMPLIFIED\n",
      "- PDGFRA Amplification: POSITIVE\n",
      "- PTEN Deletion: POSITIVE\n",
      "- MYCN Amplification by FISH: Equivocal\n",
      "- Microsatellite Instability: MSI-Stable (MSS)\n",
      "- Tumor Mutation Burden: Low\n",
      "- EGFRvIII: Not Detected\n",
      "- MGMT Promoter Methylation: Not Detected\n",
      "- PD-L1: Negative/Not Detected\n",
      "\n",
      "## Additional Information\n",
      "\n",
      "**Oncology History**: Duke University Medical Center (radiation treatment)  \n",
      "**Access to records**: Yes\n",
      "\n",
      "## Clinical Status\n",
      "\n",
      "**Current Symptoms**:  \n",
      "- Severe headaches\n",
      "- Extremity numbness\n",
      "- Elevated liver enzymes\n",
      "- Intermittent facial agnosia\n",
      "- Left-sided vision cut\n",
      "- No current seizures\n",
      "\n",
      "## Clinical Questions\n",
      "\n",
      "1. Are there updated clinical trials available for recurrent Grade 4 Astrocytoma?\n",
      "2. Are there alternative chemotherapy options for this case?\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.561\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m123\u001b[0m | \u001b[1mStart group ranking for stage 1 with 24 trials and 6 groups\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.562\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 4 trials and top_m=2\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.562\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 4 trials and top_m=2\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.562\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 4 trials and top_m=2\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.563\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 4 trials and top_m=2\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.564\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 4 trials and top_m=2\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.565\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 4 trials and top_m=2\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.565\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 4 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.566\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 4 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.566\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 4 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.567\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 4 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.568\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 4 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:35.569\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 4 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:36.420\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT05168423', 'NCT02861898']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:36.447\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT04547777', 'NCT02800486']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:36.532\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT06072586', 'NCT06047379']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:36.635\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT03896568', 'NCT05432518']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:36.699\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT04590664', 'NCT02704858']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:37.233\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT06934889', 'NCT06161974']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:37.235\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m123\u001b[0m | \u001b[1mStart group ranking for stage 2 with 12 trials and 3 groups\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:37.235\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 4 trials and top_m=2\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:37.235\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 4 trials and top_m=2\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:37.236\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 4 trials and top_m=2\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:37.236\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 4 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:37.237\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 4 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:37.239\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 4 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:38.083\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT05168423', 'NCT02704858']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:38.182\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT06072586', 'NCT06934889']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:38.311\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT04590664', 'NCT04547777']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:38.312\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m123\u001b[0m | \u001b[1mStart group ranking for stage 3 with 6 trials and 2 groups\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:38.312\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 3 trials and top_m=1\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:38.313\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 3 trials and top_m=1\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:38.313\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 3 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:38.314\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 3 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:38.926\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT04590664']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:39.143\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT02704858']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:39.144\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m123\u001b[0m | \u001b[1mStart group ranking for stage 4 with 2 trials and 1 groups\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:39.145\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m127\u001b[0m | \u001b[1mGroup ranking with 2 trials and top_m=1\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:39.145\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m61\u001b[0m | \u001b[1mGroup ranking with 2 trials\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:40.293\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mgroup_ranking\u001b[0m:\u001b[36m91\u001b[0m | \u001b[1mTop trial NCT IDs: ['NCT04590664']\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:40.294\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m149\u001b[0m | \u001b[1mFinished tournament 1.\u001b[0m\n",
      "\u001b[32m2025-06-18 18:55:40.294\u001b[0m | \u001b[1mINFO    \u001b[0m | \u001b[36mtriagent.agents.treatment.services.rerank.service\u001b[0m:\u001b[36mtournament_ranking\u001b[0m:\u001b[36m150\u001b[0m | \u001b[1mTournament 1 scores: {'NCT06934889': 2, 'NCT03749187': 0, 'NCT06186401': 0, 'NCT05432518': 1, 'NCT04197934': 0, 'NCT06047379': 1, 'NCT03175224': 0, 'NCT02861898': 1, 'NCT04931732': 0, 'NCT06059690': 0, 'NCT02704858': 3, 'NCT06327451': 0, 'NCT05052957': 0, 'NCT05313191': 0, 'NCT04547777': 2, 'NCT03919292': 0, 'NCT06894979': 0, 'NCT05256290': 0, 'NCT06161974': 1, 'NCT05168423': 2, 'NCT02800486': 1, 'NCT03896568': 1, 'NCT04590664': 4, 'NCT06072586': 2}\u001b[0m\n",
      "{'NCT06934889': 2, 'NCT03749187': 0, 'NCT06186401': 0, 'NCT05432518': 1, 'NCT04197934': 0, 'NCT06047379': 1, 'NCT03175224': 0, 'NCT02861898': 1, 'NCT04931732': 0, 'NCT06059690': 0, 'NCT02704858': 3, 'NCT06327451': 0, 'NCT05052957': 0, 'NCT05313191': 0, 'NCT04547777': 2, 'NCT03919292': 0, 'NCT06894979': 0, 'NCT05256290': 0, 'NCT06161974': 1, 'NCT05168423': 2, 'NCT02800486': 1, 'NCT03896568': 1, 'NCT04590664': 4, 'NCT06072586': 2}\n"
     ]
    }
   ],
   "source": [
    "# Test rerank service\n",
    "\n",
    "import sys\n",
    "sys.path.append('../../')\n",
    "\n",
    "from triagent.agents.therapy.services.rerank.service import TourRankService\n",
    "\n",
    "rerank_service = TourRankService()\n",
    "\n",
    "results = await rerank_service.rerank_trials(patient_info, trials)\n",
    "print(results[1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
